Explore groundbreaking cancer therapy outcomes for Medicare patients, highlighting pivotal studies on leukemia, lymphoma, and innovative treatments.

Explore study findings on Medicare Advantage beneficiaries and their access to cancer care, reflecting on network adequacy and the need for value-based models.

Discover disparities in oncology network access between Medicare Advantage and Traditional Medicare. Learn how limited networks affect cancer treatment access.

Explore how innovative blood tests like Galleri could transform cancer screening practices and insurance coverage in the U.S. early detection strategies.

Discover Malaysia's first reinsurance treaty for Cancer Precision Medicine, improving access to innovative oncology solutions and healthcare collaborations in Southeast Asia.

Study highlights the limited access of Medicare Advantage beneficiaries to oncology networks, revealing significant disparities in cancer care availability and outcomes.

Discover ASCO's updated 340B Drug Pricing Program policy aimed at enhancing access to oncology care for underserved populations.

Explore Shilpa Biocare's partnership with Gate2Brain targeting pediatric brain cancers, improving drug delivery, and enhancing shareholder value for the future.

Discover the latest OIG Advisory Opinion clarifying cancer detection practices and compliance. Learn valuable insights for healthcare companies on regulatory navigation.

Explore the complex insurance challenges surrounding high-cost cancer treatments like Keytruda and the legal battles patients face to access essential medications.